SCHEMBL13129781

SCHEMBL13129781

CCOC(=O)CCn1c(=O)[nH]c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
CYP1A2 P05177 1/20 0.57
ALDH1A1 P00352 6/20 0.53
HPGD P15428 4/20 0.53
TSHR P16473 2/20 0.53
MAPT P10636 3/20 0.51
LMNA P02545 3/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
POLB P06746 1/20 0.51
RAB9A P51151 1/20 0.51
ALOX15 P16050 1/20 0.48
TNF P01375 1/20 0.48
KDM4E B2RXH2 3/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
STAT6 P42226 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10830938 0.92 TNF (0.58) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL9139429 0.86 ALDH1A1 (0.64) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL30891925 0.86 ALDH1A1 (0.64) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2308197 0.86 MEN1 (0.56) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL7648358 0.84 KDM4E (0.67) KMT2ACYP1A2ALDH1A1HPGDMAPT
SCHEMBL7231464 0.84 ALDH1A1 (0.55) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL8119004 0.83 ADORA3 (0.47) ALDH1A1HPGDTSHRLMNASMN1; SMN2
SCHEMBL2311046 0.82 DAO (0.50) KMT2AMEN1ALDH1A1HPGDTSHR
SCHEMBL11096941 0.81 MEN1 (0.61) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL11514777 0.80 ALDH1A1 (0.71) KMT2AMEN1ALDH1A1RAB9ATNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150556-B2 Benzimidazolone chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-06 US disclosed
US-9150556-B2 Benzimidazolone chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-06 US disclosed
US-20100240702-A1 Benzimidazolone Chymase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed
US-20100240702-A1 Benzimidazolone Chymase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240702-A1 Benzimidazolone Chymase Inhibitors CMA1, SERPINB1, CPA3 KMT2A 4203/4885MEN1 1035/4885CYP1A2 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.